Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators

RT @RaulREsteban: Our policy paper on social media listening (SML) for drug development is out! Great collaboration of the expert community…

Our policy paper on social media listening (SML) for drug development is out! Great collaboration of the expert community group from @PistoiaAlliance We review the published literature and provide three different views: regulatory, industry and patient 🧵 h